West to Host Analyst and Investor Day
Marketwire - Wed May 14, 7:30AM CDT
West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the company will host an Analyst and Investor Day for financial analysts on Thursday, May 22, 2014 from 8:30 am to 11:30 am EDT in New York, NY. Members of West's senior management will provide an overview of the company's current markets, operations, and growth opportunities. Presentations will begin at 9:00 am EDT.
West Announces Third Quarter 2014 Dividend
Marketwire - Thu May 08, 6:30AM CDT
West Pharmaceutical Services, Inc. (NYSE: WST) today announced that its Board of Directors approved payment of the third-quarter 2014 cash dividend of $0.10 per share. The dividend will be paid on August 6, 2014 to shareholders of record on July 23, 2014.
West to Present at Upcoming Investor Conferences
Marketwire - Wed May 07, 5:20AM CDT
West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will participate in three upcoming investor conferences. Management will be presenting an overview of West's business and outlook at each of the following conferences:
'Mad Money' Lightning Round: Valero Is Amazing
at The Street - Tue May 06, 5:00AM CDT
Cramer does not like Plug Power but he wants Old Republic International.
Jim Cramer's 'Mad Money' Recap: Market Headwinds Getting Worse
at The Street - Mon May 05, 6:59PM CDT
Investors are just as likely to lose money as they are to make money on any given day, and there are a host of good reasons why, Cramer says.
West Announces First Quarter 2014 Results
Marketwire - Thu May 01, 6:03AM CDT
West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first quarter of 2014 and updated its financial guidance for the year.
West to Host First Quarter 2014 Conference Call
Marketwire - Thu Apr 24, 7:31AM CDT
West Pharmaceutical Services, Inc. (NYSE: WST) announced today that it will release first quarter 2014 financial results before the market opens on Thursday, May 1, 2014 and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. To participate on the call please dial 866-383-8009 (U.S.) or 617-597-5342 (International). The passcode is 97017517.
First Week of May 17th Options Trading For West Pharmaceutical Services (WST)
DividendChannel.com - Mon Apr 21, 10:06AM CDT
Investors in West Pharmaceutical Services, Inc. saw new options become available this week, for the May 17th expiration.
Dividend Watch: 2 Stocks Going Ex-Dividend Monday: WST, CLX
at The Street - Thu Apr 17, 9:00AM CDT
WST CLX are going ex-dividend Monday, Monday, April 21, 2014, 4:00 AM ET
Pharmaceutical Packaging Market by Packaging Type. Raw Material & Drug Delivery Type - Global Trends & Forecast to 2018
M2 - Wed Apr 16, 3:05AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3qkddr/pharmaceutical) has announced the addition of the "Pharmaceutical Packaging Market by Packaging Type. Raw Material & Drug Delivery Type - Global Trends & Forecast to 2018" report to their offering. The global pharmaceutical packaging market by product type and drug delivery type, has witnessed a significant growth in the past few years and this growth is estimated to persist in the coming years. The primary pharmaceutical packaging products constitute majority of the market globally. While plastic bottles, blister packs, caps & closures, labels & accessories contribute largely to the pharmaceutical packaging market; pre-fillable syringes, inhalers, medication tubes, and other new products will drive the future growth in the industry. North America, Western Europe and Japan dominated the pharmaceutical packaging market in 2012 and accounted for over 70% of the market. These developed regions dominate the packaging market due their mature markets which consist of health conscious and high-spending population. On the other hand, Asia-Pacific is expected to overtake the North American & European pharmaceutical packaging markets on account of its fastest-double digit growth rate by 2018. The market in this region is spurred by the large economies of Japan, China, and India that are experiencing increased contract manufacturing activities, growth of pharmaceutical sector, increased government investment in healthcare facilities, and ageing population. The global pharmaceutical packaging market is expected to grow at a CAGR of 6.7% from 2013 to 2018 to reach a value of $78.79 billion. The packaging market by drug delivery type is growing at a CAGR of 9.1% and constitutes a significant part of the overall pharmaceutical packaging market. The market is expected to be pushed by off-patenting of drugs, expanding generics market, and rapidly growing drug delivery market. Due to increasing generic and contract manufacturing activities in Asia-Pacific, especially in India and China, the emerging geographies are expected to register maximum growth. Key Topics Covered: - Introduction - Executive Summary - Market Overview - Premium Insight - Market Dynamics - Pharmaceutical Packaging Market, By Packaging Type - Pharmaceutical Packaging Market, By Packaging Material - Pharmaceutical Packaging Market, By Drug Delivery Type - Pharmaceutical Packaging Market, By Geography - Packaging Market For Veterinary Vaccines - Competitive Landscape - Company Profiles - Amcor Ltd. - Aptargroup, Inc. - Becton, Dickinson & Company - Capsugel Inc. - Catalent Pharma Solutions Inc. - Ccl Industries Inc. - Clondalkin Group Holdings B.V. - Datwyler Holding Inc. - Gerresheimer Ag - Global Closure Systems Ltd - Intrapac Group - Klockner Pentaplast Group - Meadwestvaco Corporation - Nypro Inc. - Rexam Plc - Rpc Group Plc - Schott Ag - Steripack Limited - Vitro, S.A.B. De C.V. - West Pharmaceutical Services, Inc. - Wihuri Group For more information visit http://www.researchandmarkets.com/research/3q...maceutical
Global Prefilled Syringes Market 2013 - 2019
M2 - Tue Apr 15, 8:30AM CDT
Research and Markets (http://www.researchandmarkets.com/research/j3vxcv/prefilled) has announced the addition of the "Global Prefilled Syringes Market 2013 - 2019" report to their offering. The two major segments described in this study are glass-based and plastic-based prefilled syringes. Each of these segments has been analyzed on the basis of their current and future market size in terms of USD million and market volume in terms of million units, considering the macro and micro environmental factors. In addition, the compounded annual growth rate (CAGR) of the overall market and the above segments has also been provided in the report for the forecast period 2013 to 2019, considering 2012 as the base year. Geographically, the market for prefilled syringes has been classified into four regions namely North America, Europe, Asia-Pacific and Rest of the World (RoW). The market size and forecast for each of these regions along with CAGR has also been provided in the report. A detailed qualitative analysis of the major market dynamics such as drivers, restraints and opportunities, along with Porter's five forces analysis and market attractiveness analysis are discussed in the market overview section of the report. The study also suggests a list of recommendations that is likely to help manufacturers in decision making process. The report concludes with a market share analysis of the leading players in the market for prefilled syringes, in terms of percentage share in the year 2012, and company profiles of the key players. The market players profiled in this report are Becton, Dickinson and Company, Gerresheimer AG, Nipro Corporation, Schott AG, Stevanato Group, Baxter, International, Inc., Unilife Corporation, West Pharmaceutical Services, Inc., Bespak, Ypsomed Holding AG and Vetter Pharma International GmbH. Scope of the Report Segment - Glass Prefilled Syringes Market - - By Revenue (USD Million) - - By Volume (Million units) - Plastic Prefilled Syringes Market - - By Revenue (USD Million) - - By Volume (Million units) Key Topics Covered: - Preface - Executive Summary - Global Prefilled Syringes Market Overview - Global Prefilled Syringes Market Revenue (USD Million) and Volume (Million Units), by Segment, 2011 - 2019 - Global Prefilled Syringes Market Revenue (USD Million) and Volume (Million Units), by Geography, 2011 - 2019 - Competitive Landscape - Recommendations - Company Profiles - Baxter International, Inc - Becton, Dickinson & Company - Bespak - Gerresheimer AG - Nipro Corporation - Schott AG - Stevanato Group - Unilife Corporation - Vetter Pharma International GmbH - West Pharmaceutical Services, Inc - Ypsomed Holding AG For more information visit http://www.researchandmarkets.com/research/j3vxcv/prefilled
West Pharmaceutical Services, Inc. Uses Esker Cloud Fax Services to Simplify and Streamline Faxing
Business Wire - Tue Apr 15, 7:01AM CDT
Esker, a worldwide leader in document process automation solutions and SAP(R) software solution and technology partner, announced today that West Pharmaceutical Services, Inc. (West), a designer and manufacturer of pharmaceutical packaging and delivery systems, is leveraging Esker Cloud Fax Services to automate its inbound and outbound faxing. The initiative allows West to increase the speed, accuracy and reliability of its faxing operations while achieving full reporting capabilities within the SAP interface.
Earnings Release Schedules, Product Portfolio Expansion, Initiatives and Stock Price Movements - Analyst Notes on Biogen Idec, Bristol-Myers, Regeneron Pharma, Illumina, West Pharma Services
PR Newswire - Tue Apr 08, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Biogen Idec Inc. (NASDAQ: BIIB), Bristol-Myers Squibb Company (NYSE: BMY), Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), Illumina Inc. (NASDAQ: ILMN), and West Pharmaceutical Services, Inc. (NYSE: WST). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
West to Present at Barclays Conference
Marketwire - Thu Mar 06, 7:02AM CST
West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will attend the 2014 Barclays Global Healthcare Conference Healthcare Conference in Miami, FL. Management will present an overview of West's business and outlook on Thursday, March 13, 2013 at 9:00 AM Eastern Time.
Concise Analysis of the International Bolus Injectors Market, 2014 - 2024
M2 - Tue Mar 04, 6:22AM CST
Research and Markets (http://www.researchandmarkets.com/research/jpbd3g/bolus_injectors) has announced the addition of the "Concise Analysis of the International Bolus Injectors Market, 2014 - 2024" report to their offering. The injectable drug delivery market holds significant potential for the future. From conventional syringes with vials and painful needles to the modern-day pre-filled syringes, pen-injectors, needle free injectors and auto-injectors, the injectable drug delivery devices market has come a long way. Taking the concept of self-injectors to a new stratum, Bolus Injectors' have surfaced recently. Also known as non-insulin patch pumps, these devices not only offer a range of benefits to the end users but also provide a number of additional benefits to other stakeholders in the industry. One of the main drivers for the perceived growth of bolus injectors is the large number of biologics currently under development. A majority of these molecules are highly viscous and are required to be delivered in volumes of greater than 1 ml. The absence of devices which can safely administer these drugs is currently a big unmet need in the market. However, the early signs are encouraging. Despite the uncertainties related to the device development and approval, many companies are investing time, money and resources to develop novel devices. Key Topics Covered: 1. Executive Summary 2. Introduction 3. Overview And Market Background 4. Target Drugs For Bolus Injectors 5. Product Profiles 6. Market Size And Forecast 7. Swot Analysis 8. Company Profiles 9. Interview Transcripts 10. Conclusion 11. Appendix 1: Tables 12. Appendix 2: List Of Companies Companies Mentioned: - AbbVie - Abbott - BMS - Boehringer Ingelheim - Calando Pharmaceuticals - Calibra Medical - Dekkun - Denderon - Eisai - Elcam Medical - Eli Lilly - Five Prime Therapeutics - Future Injection Technologies - Genentech - Genethon - Isis Pharmaceuticals - J&J - Janssen Biotech - Kyowa Hakko Kirin - Lincoln Medical Limited - MacroGenics - Nuron Biotech - Octapharma - OncoGenex Technologies - Pfizer - PhaseBio Pharmaceuticals - Roche - SteadyMed Therapeutics - Synageva BioPharma - TaiMed Biologics - Takeda Pharmaceuticals - VBL Therapeutics - West Pharmaceutical Services - Xbiotech - Ypsomed - ZZ Biotech For more information visit http://www.researchandmarkets.com/research/jp..._injectors
Insider Trading Alert - KMB, IBKR And WST Traded By Insiders
at The Street - Thu Feb 27, 9:30AM CST
Stocks with insider trader activity include KMB, IBKR and WST
Progress Watch Corp. to Enter Social/Content Marketing Arena
Marketwire - Tue Feb 25, 9:13AM CST
Progress Watch Corporation (PINKSHEETS: PROW) announced that it will enter the social/ content marketing arena. With more than one billion smart phone users and 1.7 billion expected by 2017, this move from its traditional core business line mechanical movement manufacturing and watch supply businesses) is expected to develop new revenue streams for the company, especially in the area of social/content marketing. Companies will have the ability to target specific markets to stream branded messages.
West Pharm sales fall short
at Investor's Business Daily - Thu Feb 20, 6:14PM CST
The maker of packaging and delivery devices for drugs and related consumer products said Q4 EPS climbed 22.6% to 38 cents, in line with estimates. Revenue rose 7.8% to $346.6 mil, below projections for $348.7 mil. West Pharmaceutical (WST) forecast...
West Appoints Director and Announces Second Quarter 2014 Dividend
Marketwire - Thu Feb 20, 7:22AM CST
West Pharmaceutical Services, Inc. (NYSE: WST) today announced that its Board of Directors increased the size of the Board to eleven and appointed Myla Lai-Goldman, M.D., for a term that will expire at the 2014 Annual Meeting of Shareholders, when she will stand for election.
West Announces Fourth Quarter 2013 Results
Marketwire - Thu Feb 20, 6:01AM CST
West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth quarter and full year 2013 and provided annual financial guidance for 2014.